Show simple item record

dc.contributor.authorMasaba, S. Cen
dc.contributor.authorWorld Health Organizationen
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-17T00:14:38Z
dc.date.available2012-06-17T00:14:38Z
dc.date.created1983en
dc.date.issued1983en
dc.identifier.govdocWHO/MAL/83.998en
dc.identifier.urihttps://apps.who.int/iris/handle/10665/65887
dc.descriptionDocuments : WHO/MAL/82.976-82.989, WHO/MAL/83.990-83.991, WHO/MAL/83.992 (‎WHO/VBC/83.873)‎, WHO/MAL/83.993-83.998, WHO/MAL/83.999 (‎WHO/VBC/83.878)‎, WHO/MAL/83.1000-83.1003, WHO/MAL/84.1004-84.1006, WHO/MAL/84.1007 (‎WHO/VBC/84.898)‎, WHO/MAL84.1008 (‎WHO/VBC/84.899)‎, WHO/MAL(‎84.1009-84.1012, WHO/MAL/84.1013 (‎WHO/VBC/84.905)‎, WHO/MAL/84.1014-84.1015, WHO/MAL/84.1016 (‎WHO/VBC/84.908)‎, WHO/MAL/85.1017 (‎WHO/VBC/85.910)‎, WHO/MAL/85.1018-85.1021, WHO/MAL/86.1022-86.1033, WHO/MAL/87.1034-87.1036, WHO/MAL/87.1037 (‎WHO/VBC/87.944)‎, WHO/MAL/87.1038-87.1040, WHO/MAL/87.1041 (‎WHO/VBC/87.951)‎, WHO/MAL/87.1042, WHO/MAL/88.1043-88.1050, WHO/MAL/89.1051 (‎WHO/VBC/89.966)‎, WHO/MAL/89.1052-89.1054, WHO/MAL/90.1055-90.1057, WHO/MAL/90.1058 (‎WHO/VBC/90.985)‎, WHO/MAL/90.1059-90.1060, WHO/MAL/90.1061 (‎WHO/VBC/90.989)‎, WHO/MAL/91.1062 (‎WHO/VBC/91.994)‎, WHO/MAL/91.1063, bound in 1 volen
dc.descriptionSummary in French p. 3en
dc.descriptionWHO/MAL/83.998en
dc.description5 p.en
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.meshMalariaen
dc.subject.meshPlasmodium falciparumen
dc.subject.meshPyrimethamineen
dc.subject.meshSulfadoxineen
dc.subject.meshChloroquineen
dc.subject.meshDrug Resistance, Microbialen
dc.subject.meshKenyaen
dc.subject.otherParasitic Diseases and their Controlen
dc.titleSensitivity of Plasmodium falciparum to antimalarial drugs in Nandi District, Kenyaen
dc.subject.meshqualifierprevention and control drug therapyen
dc.subject.meshqualifierdrug effectsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record